Maja Mockenhaupt

Freiburg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

Thyrostatic Drugs and Severe Skin Reactions: A Registry Evaluation Over 20 Years.

Thyrostatic Drugs and Severe Skin Reactions: A Registry Evaluation Over 20 Years.

Journal: Deutsches Arzteblatt international

Published: April 20, 2026

Response to the Letter Regarding "Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Induced by Meropenem in a Patient Under Therapy With Avelumab and Subsequent Flare-up".

Response to the Letter Regarding "Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Induced by Meropenem in a Patient Under Therapy With Avelumab and Subsequent Flare-up".

Journal: Journal of investigational allergology & clinical immunology

Published: January 14, 2026

"Drug Reaction with Eosinophilia and Systemic Symptoms" (DRESS): Long-term Outcomes Based on Severity - A Cohort Study.

"Drug Reaction with Eosinophilia and Systemic Symptoms" (DRESS): Long-term Outcomes Based on Severity - A Cohort Study.

Journal: Acta dermato-venereologica

Published: December 30, 2025

Descriptive Analysis of Reports of Drug Reaction with Eosinophilia and Systemic Symptoms from EudraVigilance and from the RegiSCAR Project.

Descriptive Analysis of Reports of Drug Reaction with Eosinophilia and Systemic Symptoms from EudraVigilance and from the RegiSCAR Project.

Journal: Dermatology (Basel, Switzerland)

Published: December 16, 2025

Real-World Burden of Generalized Pustular Psoriasis in a French Observational Study: Prevalence, Incidence, Healthcare Resource Utilization, Comorbidities, Treatment Use, and Mortality.

Real-World Burden of Generalized Pustular Psoriasis in a French Observational Study: Prevalence, Incidence, Healthcare Resource Utilization, Comorbidities, Treatment Use, and Mortality.

Journal: Dermatology and therapy

Published: November 27, 2025

Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Induced by Meropenem in a Patient Receiving Avelumab and Subsequent Flare-Up.

Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Induced by Meropenem in a Patient Receiving Avelumab and Subsequent Flare-Up.

Journal: Journal of investigational allergology & clinical immunology

Published: July 03, 2025

Epidermal necrolysis (Stevens-Johnson syndrome/ toxic epidermal necrolysis) as extensive boundary violation: A qualitative study on the illness experience and care needs of survivors in the context of the first German guideline.

Epidermal necrolysis (Stevens-Johnson syndrome/ toxic epidermal necrolysis) as extensive boundary violation: A qualitative study on the illness experience and care needs of survivors in the context of the first German guideline.

Journal: PloS one

Published: May 06, 2025

Targetoid maculae with vesicle formation and erosions

Targetoid maculae with vesicle formation and erosions

Journal: Dermatologie (Heidelberg, Germany)

Published: March 11, 2025

Systemic immunomodulating therapies for epidermal necrolysis (Stevens-Johnson syndrome/toxic epidermal necrolysis): A systematic review and meta-analysis.

Systemic immunomodulating therapies for epidermal necrolysis (Stevens-Johnson syndrome/toxic epidermal necrolysis): A systematic review and meta-analysis.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: February 04, 2025

Title Not Found

Title Not Found

Journal: MMW Fortschritte der Medizin

Published: July 12, 2024

S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 2: Supportive therapy of EN in the acute and post-acute stages.

S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 2: Supportive therapy of EN in the acute and post-acute stages.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: June 12, 2024

S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 1: Diagnosis, initial management, and immunomodulating systemic therapy.

S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 1: Diagnosis, initial management, and immunomodulating systemic therapy.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: June 12, 2024

Showing 1-12 of 92

Last Updated: 09/26/2026